MCE - Delayed Quote EUR
Pharma Mar, S.A. (PHM.MC)
At close: November 6 at 5:35 PM GMT+1
Research Analysis
Revenue vs. Earnings
Revenue 45.66M
Earnings 3.9M
Q4'23
Q1'24
Q2'24
Q3'24
0
10M
20M
30M
40M
Analyst Price Targets
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2022) | Next Qtr. (Mar 2023) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 8 | 8 |
| Avg. Estimate | 0 | 0 | 3.15 | 3.69 |
| Low Estimate | 0 | 0 | 2.29 | 1.43 |
| High Estimate | 0 | 0 | 5.42 | 8.09 |
| Year Ago EPS | -- | -- | 5.13 | 3.15 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2022) | Next Qtr. (Mar 2023) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 7 | 7 |
| Avg. Estimate | -- | -- | 181.03M | 188.63M |
| Low Estimate | -- | -- | 111M | 90M |
| High Estimate | -- | -- | 202M | 239M |
| Year Ago Sales | -- | -- | 229.83M | 181.03M |
| Sales Growth (year/est) | -- | -- | -21.20% | 4.20% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2022) | Next Qtr. (Mar 2023) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 3.15 | 3.69 |
| 7 Days Ago | 0 | 0 | 3.15 | 3.69 |
| 30 Days Ago | 0 | 0 | 3.08 | 3.72 |
| 60 Days Ago | 0 | 0 | 3.32 | 4.13 |
| 90 Days Ago | 0 | 0 | 3.32 | 4.13 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2022) | Next Qtr. (Mar 2023) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 3 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | PHM.MC | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 5.50% |
| Next Qtr. | -- | -- | -- | 11.40% |
| Current Year | -38.60% | -- | -- | 2.10% |
| Next Year | 17.10% | -- | -- | 12.30% |
| Next 5 Years (per annum) | 47.70% | -- | -- | 11.11% |
| Past 5 Years (per annum) | -22.54% | -- | -- | -- |
Related Tickers
ORY.MC Oryzon Genomics S.A.
1.6240
+0.25%
ROVI.MC Laboratorios Farmaceuticos Rovi, S.A.
75.65
-1.24%
ATRY.MC Atrys Health, S.A.
3.1300
-0.63%
PULM Pulmatrix, Inc.
2.1300
+3.40%
LPTX Leap Therapeutics, Inc.
3.7100
+4.51%
UR8.SG UroGen Pharma Ltd
11.00
+0.92%
22Z.BE Zealand Pharma A/S
112.70
+3.30%
CRIS Curis, Inc.
4.2000
-4.98%
XTLB.TA XTL Biopharmaceuticals Ltd.
6.50
+1.56%
0NZU.IL Zealand Pharma A/S
868.50
+4.61%